Kalkine has a fully transformed New Avatar.

BWX Technologies Inc

Industrials US BWXT

129.72USD
0.78(0.60%)

Last update at 2025-06-06T20:00:00Z

Day Range

128.52130.00
LowHigh

52 Week Range

74.00136.05
LowHigh

Fundamentals

  • Previous Close 128.94
  • Market Cap11174.40M
  • Volume730513
  • P/E Ratio40.46
  • Dividend Yield0.76%
  • EBITDA422.89M
  • Revenue TTM2682.90M
  • Revenue Per Share TTM29.29
  • Gross Profit TTM 551.93M
  • Diluted EPS TTM3.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 314.38M 395.71M 362.17M 313.74M 280.14M
Minority interest -0.42900M 0.42M 0.53M 0.56M 0.35M
Net income 238.19M 305.87M 278.67M 244.12M 226.96M
Selling general administrative 234.28M 230.40M 231.17M 216.77M 214.09M
Selling and marketing expenses - - - - -
Gross profit 551.93M 550.28M 575.40M 533.86M 504.01M
Reconciled depreciation 73.84M 69.08M 60.67M 61.72M 60.10M
Ebit 348.57M 345.85M 358.55M 325.52M 308.03M
Ebitda 430.15M 497.02M 452.50M 413.61M 368.13M
Depreciation and amortization 81.58M 151.17M 93.95M 88.09M 60.10M
Non operating income net other -34.19400M 49.87M 3.62M -11.77900M -24.83200M
Operating income 348.57M 345.85M 358.55M 325.52M 304.98M
Other operating expenses 1924.72M 1815.26M 1793.48M 1595.50M 1525.19M
Interest expense 36.41M 35.76M 31.01M 35.32M 27.82M
Tax provision 75.76M 89.42M 82.98M 69.06M 52.84M
Interest income 0.76M 0.42M 0.52M 0.94M 2.48M
Net interest income -35.65200M -35.34200M -30.49600M -34.37800M -25.34400M
Extraordinary items - - - - 13.50M
Non recurring 5.52M -3.53200M -1.36100M 2.82M 0.06M
Other items - - - - -
Income tax expense 75.76M 89.42M 82.98M 69.06M 52.84M
Total revenue 2232.83M 2124.07M 2123.52M 1894.92M 1799.89M
Total operating expenses 243.82M 241.46M 245.36M 234.44M 229.31M
Cost of revenue 1680.90M 1573.80M 1548.12M 1361.06M 1295.88M
Total other income expense net -34.19400M 49.87M 3.62M -11.77900M 30.79M
Discontinued operations - - - - -
Net income from continuing ops 238.62M 306.29M 279.20M 244.68M 227.31M
Net income applicable to common shares 238.19M 305.87M 278.67M 244.12M 226.96M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2747.07M 2618.94M 2501.38M 2293.50M 1908.91M
Intangible assets 185.51M 193.61M 185.55M 192.75M 191.39M
Earning assets - - - - -
Other current assets 36.92M 55.04M 47.72M 44.26M 41.46M
Total liab 1813.76M 1870.58M 1864.14M 1675.73M 1504.80M
Total stockholder equity 933.35M 748.31M 637.17M 617.77M 404.11M
Deferred long term liab - - - - -
Other current liab 130.75M 145.77M 158.15M 173.06M 143.90M
Common stock 1.28M 1.28M 1.27M 1.27M 1.27M
Capital stock 1.28M 1.28M 1.27M 1.27M 1.27M
Retained earnings 2093.92M 1932.97M 1775.75M 1549.95M 1344.38M
Other liab - 202.09M 204.08M 277.86M 286.49M
Good will 297.02M 293.17M 285.50M 283.71M 275.50M
Other assets - 67.75M 69.71M 104.51M 113.29M
Cash 78.62M 35.24M 33.89M 42.61M 86.54M
Cash and equivalents - - - - -
Total current liabilities 375.05M 367.86M 459.62M 529.73M 404.71M
Current deferred revenue 107.39M 88.73M 111.62M 83.58M 75.42M
Net debt 1151.28M 1253.63M 1155.41M 908.82M 737.61M
Short term debt 10.25M 6.25M - 88.69M 14.71M
Short long term debt 6.25M 6.25M - 88.69M 14.71M
Short long term debt total 1229.91M 1288.87M 1189.30M 951.42M 824.15M
Other stockholder equity -1154.38400M -1164.00700M -1151.99200M -941.65200M -934.09500M
Property plant equipment - 1134.90M 1045.64M 816.47M 580.24M
Total current assets 817.80M 771.62M 773.73M 773.60M 629.75M
Long term investments 98.10M 108.30M 85.28M 71.81M 70.12M
Net tangible assets - 261.53M 166.12M 141.31M -62.78800M
Short term investments 2.99M 3.80M 3.81M 3.71M 5.84M
Net receivables 674.86M 674.61M 685.42M 679.96M 492.85M
Long term debt 1203.42M 1282.62M 1189.30M 862.73M 809.44M
Inventory 27.40M 2.93M 2.90M 3.07M 3.06M
Accounts payable 126.65M 127.11M 189.84M 184.39M 170.68M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 0.04M 0.06M 0.00200M 0.00600M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -7.46300M -21.93000M 12.14M 8.20M -7.44800M
Additional paid in capital - - - - -
Common stock total equity - 1.28M 1.27M 1.27M 1.27M
Preferred stock total equity - - - - -
Retained earnings total equity - 1932.97M 1775.75M 1549.95M 1344.38M
Treasury stock - - -1326.28000M -1095.45200M -1068.16400M
Accumulated amortization - - - - -
Non currrent assets other 57.28M 96.77M 94.72M 96.40M 95.60M
Deferred long term asset charges - - - - -
Non current assets total 1929.26M 1847.32M 1727.65M 1519.90M 1279.16M
Capital lease obligations - - - - -
Long term debt total - 1282.62M 1189.30M 862.73M 809.44M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -168.14500M -256.23600M 0.81M 2.13M 1.67M
Change to liabilities - -60.20700M 30.92M 6.76M 26.62M
Total cashflows from investing activities - -256.23600M -304.65300M -265.31900M -179.99500M
Net borrowings - 97.59M 220.72M 131.72M 45.51M
Total cash from financing activities -169.37100M 13.95M -90.13600M 25.05M -43.71300M
Change to operating activities - -76.79500M -64.52100M -23.14300M -20.48600M
Net income 245.85M 238.62M 306.29M 279.20M 244.68M
Change in cash 40.62M 1.22M -8.52300M -44.10200M 55.99M
Begin period cash flow 40.99M 39.77M 48.30M 92.40M 36.41M
End period cash flow 81.61M 40.99M 39.77M 48.30M 92.40M
Total cash from operating activities 363.70M 244.70M 386.03M 196.44M 279.37M
Issuance of capital stock - - - - -
Depreciation 78.57M 73.84M 69.08M 60.67M 61.72M
Other cashflows from investing activities - -57.93400M 5.58M -12.42000M 0.46M
Dividends paid -84.97400M 81.07M 79.67M 72.94M 65.37M
Change to inventory - - -1.99100M 6.84M -14.13500M
Change to account receivables 0.46M 19.36M 87.88M -106.88000M 27.08M
Sale purchase of stock -7.59200M -26.58800M -230.82800M -27.20900M -29.19000M
Other cashflows from financing activities 4.45M 999.81M -7.22700M -16.13500M 0.90M
Change to netincome - 23.83M 47.08M 21.80M 8.55M
Capital expenditures 151.29M 198.31M 311.05M 255.03M 182.12M
Change receivables - 15.17M 84.01M -98.30200M 15.61M
Cash flows other operating - -46.59400M -155.56200M -73.68000M -78.77400M
Exchange rate changes - - - - 0.33M
Cash and cash equivalents changes - 2.42M -8.76300M -43.83100M 55.99M
Change in working capital -16.67500M -141.50200M -14.74100M -174.77100M -42.76700M
Stock based compensation 15.90M 14.13M 18.61M 16.84M 12.73M
Other non cash items 45.19M 54.10M -33.30500M 6.61M -0.78400M
Free cash flow 212.41M 46.39M 74.97M -58.58500M 97.24M

Peer Comparison

Sector: Industrials Industry: Aerospace & Defense

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BWXT
BWX Technologies Inc
0.78 0.60% 129.72 40.46 36.76 4.17 10.88 4.74 26.38
BA
The Boeing Company
1.78 0.85% 210.80 - 294.12 1.68 - 2.25 111.56
EADSY
Airbus Group NV
-0.09 0.19% 47.09 27.76 21.51 1.93 7.21 1.79 13.93
EADSF
Airbus Group SE
-4.98 2.57% 188.62 27.24 21.28 1.91 7.14 1.79 13.93
RTX
Raytheon Technologies Corp
0.03 0.02% 139.10 38.65 15.77 1.77 1.69 2.22 16.02

Reports Covered

Stock Research & News

Profile

BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers. This segment also involved in manufacture of close-tolerance and equipment for nuclear applications; down blend government stockpiles of uranium; receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials; and supplies research reactor fuel elements for colleges, universities, and national laboratories, as well as components for defense applications. The Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, and reactor components; and other auxiliary equipment, including containers for the storage of nuclear fuel and other high-level nuclear waste. This segment also offers nuclear fuel, fuel handling systems, tooling delivery systems, nuclear grade materials, and precisely machined components, and related services for CANDU nuclear power plants; provides in-plant inspection, maintenance, and modification services, as well as non-destructive examination and tooling/repair solutions; and manufactures medical radioisotopes, radiopharmaceuticals, and medical devices. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.

BWX Technologies Inc

800 Main Street, Lynchburg, VA, United States, 24504

Key Executives

Name Title Year Born
Mr. Rex D. Geveden Pres, CEO & Director 1962
Mr. Robb A. LeMasters Sr. VP & CFO 1978
Mr. Thomas E. McCabe Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. 1955
Mr. Richard W. Loving Special Advisor 1956
Mr. Robert L. Duffy Sr. VP & Chief Admin. Officer 1967
Mr. Mark A. Kratz VP of Investor Relations NA
Mr. John R. MacQuarrie Pres of Commercial Operations Segment NA
Ms. Heatherly H. Dukes Pres of BWXT Technical Services Group Inc NA
Ms. Suzanne C. Sterner Sr. VP & Chief Corp. Affairs Officer NA
Dr. Jonathan W. Cirtain Ph.D. Sr. VP, Chief Devel. Officer and Pres & CEO of BWXT Medical Ltd NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.